1: NOTIFICATION OF MAJOR INTEREST IN SHARES
|
1. Identity of the issuer or the underlyingissuer of existing shares to which votingrights are attached: |
Immupharmaplc |
||||||||
|
2. Reason for the notification (please tick the appropriate box or boxes): |
|||||||||
|
An acquisition or disposal of voting rights |
x |
||||||||
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|||||||||
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|||||||||
|
An event changing the breakdown of voting rights |
|||||||||
|
Other (please specify): The placement by ImmuPharma PLC of 2,856,539 new ordinary shares |
x |
||||||||
|
3. Full name of person(s) subject tothe notification obligation: |
Lanstead Capital LP |
||||||||
|
4. Full name of shareholder(s) (if different from 3.): |
|||||||||
|
5. Date of the transaction and date on which the threshold is crossedor reached: |
4 March 2016 |
||||||||
|
6. Date on which issuer notified: |
4 March 2016 |
||||||||
|
7. Threshold(s) that is/are crossedor reached: |
15% |
||||||||
|
8. Notified details: |
|||||||||
|
A: Voting rights attached to shares |
|||||||||
|
Class/type of shares
if possibleusing theISIN CODE |
Situation previous to the triggeringtransaction |
Resulting situation after the triggering transaction |
|||||||
|
Number of Shares |
Number ofVoting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||||
|
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||||
|
GB0033711010 |
17,872,341 |
17,872,341 |
17,893,456 |
17,893,456 |
14.69% |
||||
